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Leucine rich repeats and immunoglobulin-like domains protein 1 (LRIG1) is a 
transmembrane protein that negatively regulates intestinal epidermal growth factor 
receptors (EGFRs) on the cell surface. This evidence suggests that LRIG1 suppresses 
cell growth and decreases the rate of cellular division within the intestine. Indeed, 
colonic tumorigenesis is observed in Lrig1-/- mice, definitively proving that LRIG1 is an 
intestinal tumor suppressor protein necessary for tissue homeostasis. Leucine rich 
repeats and immunoglobulin-like domains protein 3 (LRIG3) localization and 
functionality are fairly unknown. However, LRIG3 shares many morphological 
characteristics of LRIG1, which suggests LRIG3 may have similar localization and 
functionality as LRIG1. Indeed, current studies support this hypothesis, leading this 
paper to suggest LRIG3 may act as a redundant pathway for tumor suppression for 
LRIG1 within the colon. As such, this study analyzes shifts in colonic crypt LRIG1 
localization in the absence of Lrig3. An upward trend in LRIG1-expressing cells is 
observed in the colonic crypts of Lrig3-/- mice, suggesting that Lrig3 product may 
  
iii  
restrict the upward migration of LRIG1. A concurrent decrease in Ki67/LRIG1 co-
positive cells within these colonic crypts supports the observation that LRIG1 levels 
increase in absence of Lrig3 product. Therefore, this study suggests that LRIG3 may be 
localized above LRIG1 within the colonic crypt, and that absence of LRIG3 causes 
LRIG1 to extend its localization, possibly in order to act as a tumor suppressor in cells 
that would normally possess the redundant tumor suppressor LRIG3.    
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Introduction 
Background: The colon 
In order to convert the chemical energy contained within food into usable energy 
for powering the body, many organisms require a digestive system specialized in both 
breaking down food into nutrients and in eliminating food waste that is not taken up by 
the body. For the second part of this process, vertebrates possess a long, tubular organ 
called the large intestine, of which the cecum, colon, rectum, and anal canal are all 
considered a part of and which Figure 1 displays. The location of focus for this paper is 
the composite colon of the large intestine. 
 
Figure 1: Anatomy of the large intestine. 
The large intestine contains the cecum, ascending colon, transverse colon, descending 
colon, sigmoid colon, rectum, and anus. This organ functions primarily to absorb water 
into the bloodstream and to condense waste material into feces for defecation. 
(Blausen.com staff (2014). "Medical gallery of Blausen Medical 2014". WikiJournal of 
Medicine 1(2). DOI:10.15347/wjm/2014.010. ISSN 2002-4436.) 
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Chyme1 that enters the large intestine from the small intestine will contain few 
nutrients and only around 10% of its original water content due to the absorptive nature 
of the preceding gastrointestinal tract. Even so, the colon will absorb most of the 
remaining water from the chyme as well as any remaining nutrients. Consequently, the 
indigestible parts of the ingested food, such as amylose and dietary fiber, will constitute 
the majority of the material that the large intestine processes. Bacteria living within the 
colon are able to break down some of the undigested carbohydrates for their own 
sustenance, producing acetate, propionate, and butyrate as waste products (Miller and 
Wolin et al., 1996). These short chain fatty acids are taken up by cells lining the colon 
as a means of nourishment. Furthermore, colonic bacteria produce important nutrients 
such as vitamin K, vitamin B12, thiamine, and riboflavin that are absorbed by the colon 
for distribution and use in the host body. As the chyme mixes with mucus and bacteria, 
it becomes a watery feces that solidifies the farther it travels down the colon, eventually 
forming a solid stool ready for elimination.  
The colonic crypt  
Many tissues within the body undergo a constant process of regeneration in 
order to replace the millions of cells that are lost either through natural cell death or 
injury (Wath et al., 2013). This process must be tightly controlled in order to prevent 
malignancies from arising as a result of unregulated cell growth, such as when a tumor 
forms. The intestinal lumen2 is one of the fastest sites of cellular self-renewal, with the 
                                                        
1 Cyme – the semi-fluid mass of gastric juices and partly digested food that leaves the stomach and passes 
through the small intestine before entering the large intestine. 
2 Lumen – the inside space of a tubular structure; in this case, the intestinal lumen is the hollow inside of 
the pipe-like small and large intestine. 
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entire intestinal epithelium3 replaced every 3-5 days in humans due to the 
approximately 1011 epithelial cells that are sloughed off daily by the passage of chyme 
(Wath et al., 2013). This monolayer of rapidly regenerating epithelial cells functions to 
absorb water and nutrients into the bloodstream, while at the same time forming a 
protective barrier against pathogens4 and harmful substances.  
These new, functional epithelial cells are produced from highly proliferative 
stem cells5 found at the base of small, tubular pits called crypts that line the entire 
intestinal tract and number in the millions (Figure 2).  
                                                        
3 Epithelial – the thin tissue lining the outside of the body and the inside of hollow structures within the 
body; the intestinal lumen is lined by this tissue. 
4 Pathogens – bacteria, viruses, or other microorganisms that can cause disease. 
5 Stem cell – a cell with the ability to indefinitely produce more cells of the same type, and from which 
other, specialized cells can arise via the process of differentiation. 
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Figure 2: Intestinal crypt cell morphology. 
The lining of the colon is punctured by invaginations that form pockets of tissue called 
crypts (left) (Barker, 2014). Crypts possess a base of self-renewing stem cells above 
which differentiated daughter cells maintain the morphology and biochemical 
environment of the crypt (right) (Powell Lab, 2017). 
The very bottom, or most basal, cell of the colonic crypt is designated ‘0’; the next cell 
up on either side of the crypt is labeled as ‘+1’, the cell after that ‘+2’, and so forth. 
Referring to a cell within the crypt will therefore done with a ‘+position’ label. The 
greater the +position number, the more lumenal (closer to the lumen of the colon) the 
cell is. Specific, specialized cells are often found in only certain +positions within the 
crypt.  
Recent Ki676 immunostains7 suggest that there is a relatively sharp distinction 
between the proliferative, primitive stem cells at the base of the crypt and the mature, 
fully differentiated8 colonocytes further up the crypt wall (Leedham et al., 2012). The 
direct progeny of these stem cells, termed transit-amplifying (TA) cells, are semi-                                                        
6 Ki67 – a nuclear protein that is used in immunohistochemistry as a marker for cell proliferation; it is an 
excellent marker for determining the growth fraction of a cell population. 
7 Immunostain – an antibody-based method of detecting a specific protein in a sample. 
8 Differentiated – when a cell changes from one cell type to another, usually more specialized, type. 
lumen 
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differentiated and proliferate for several rounds of division before withdrawing from the 
cell cycle and migrating up the crypt wall, after which they differentiate into mature 
cells (Potten and Loeffler, 1990). Altogether, the colonic crypt is divided up into three 
fairly distinct sections: a base of stem cells, TA cells just above the stem cells, and fully 
differentiated and mature cells that make up the rest of the crypt wall. 
As such, cell production, differentiation, migration, and turnover9 of this tissue 
is tightly regulated by mechanisms that ensure the quality and proper rate of epithelial 
cell maturation and detachment. Dysregulation or malfunction of any of these processes 
is strongly correlated with the development of gastrointestinal disease and the formation 
of invasive tumors (Radtke and Clevers et al., 2005) (Boman et al., 2008).   
Background: Leucine rich repeats and immunoglobulin-like domains  
Leucine rich repeats and immunoglobulin-like domains (LRIG10) is an 
evolutionarily conserved11, single-pass transmembrane12 protein family that modulates 
several signaling pathways within the cell. Specifically, the LRIG family has been 
implicated as essential regulators of tyrosine and serine/threonine kinase13 growth factor 
receptors (Simion et al., 2014). In vertebrates, there are three protein members – 
LRIG1, LRIG2, and LRIG3 – that have been speculated to be mechanistically similar 
due to their highly related morphology. This morphology consists of leucine-rich                                                         
9 Cell turnover – the process by which new cells travel from one position to another before being shed; 
this process prevents the buildup of dead cells. 
10 Protein products of genes are fully capitalized, while names of genes are italicized. 
11 Genes (and their products) that are evolutionarily conserved are usually unique and essential for the 
organism’s health. 
12 Single-pass transmembrane (protein) – a protein with one part of itself that is extracellular and one part 
that is intracellular; these two parts are connected by a domain that rests within the lipid bilayer of the 
cell. 
13 Kinase – a family of enzymes that catalyze the transfer of a phosphoryl group from a nucleotide 
triphosphate donor (such as ATP) to an acceptor molecule. This phosphorylation can control enzyme 
activity, subcellular localization, interactions between molecules, and signal transduction cascades. 
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repeats, three immunoglobulin-like domains, a transmembrane domain, and a large 
cytoplasmic tail14 (Figure 3).  
          
Figure 3: Leucine rich repeats and immunoglobulin-like domains (LRIG). 
This transmembrane protein has both an extracellular domain and an intracellular 
domain, linked by a transmembrane domain that resides in the lipid bilayer of the cell 
(Simion et al., 2014). 
Healthy human tissue broadly expresses LRIGs; indeed, at least twenty-six distinct 
tissue types have been found to contain detectable amounts of LRIG transcripts (Guo et 
al., 2004). 
 While similar homology is shared in the extracellular domains and also in the 
juxtamembrane portion of their cytoplasmic domains, LRIGs diverge significantly from 
each other in the remainder of their cytoplasmic domain. As this portion of the protein 
is responsible for the direct regulation of its host cell, unique functions may be seen 
between the different LRIGs (Abraira et al., 2010).                                                          
14 Cytoplasmic tail – a part of a protein that extends into the interior (cytoplasmic) portion of a cell. 
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LRIG1 
Intestinal LRIG1 is able to control cell growth via negative regulation of 
epidermal growth factor receptor (EGFR) signaling, also known as ErbB receptors 
(Powell et al., 2012). EGFRs are transmembrane proteins that bind extracellular growth 
factors; as a result of binding, the receptor initiates a cascade of biochemical responses 
within the cell, the final outcome being one of cell growth promotion. Because LRIG1 
functions to restrict the activity of EGFR – and as a result repress cell growth – it is 
considered a tumor suppressor, or gene product that helps to prevent the transformation 
of a healthy cell into a cancerous cell. Figure 4 summarizes both the normal mechanistic 
pathways of EGFR, as well as how LRIG1 inhibits these mechanisms.  
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Figure 4: LRIG1 inhibition of an epidermal growth factor receptor (EGFR) signaling 
cascade. 
Ecto-domain interaction of LRIG1 is thought to initiate EGFR ubiquitination and 
degradation, leading to decreased growth promotion of the cell (Wang et al., 2013). 
Evidence supporting LRIG1’s functionality as a tumor suppressor resulted in several 
studies that analyzed the relationship between LRIG1 and cancer. It was found that 
most, but not all, cancer types examined had decreased levels of LRIG1 relative to 
normal tissue, with greater decreases in expression associated with worse patient 
prognoses (Rouam et al., 2010). This suggests that LRIG1 dysregulation may contribute 
to tumor formation and/or severity. 
Lrig1 mRNA lineage tracing15 revealed cell labeling of the crypt base that, over 
time, populated the entire crypt; this confirmed that intestinal stem cells are marked by 
Lrig1, and that the LRIG1 protein may be a stem cell marker (Figure 5).  
                                                        
15 Lineage tracing – identifies all progeny of a cell; in this case, the progeny of colonic crypt stem cells. 
j 
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Figure 5: Lineage tracing of Lrig1-positive cells in the colonic crypt.  
β-galactosidase activity (blue) reflected Lrig1 mRNA expression over time. Initially 
labeled crypts contained at least one or two β-gal-positive cells, virtually all of which 
were located at the base of the crypt (H1). Seven days later, β-gal staining was more 
widespread, indicating proliferation of initially tagged cells that had produced β-gal-
positive progeny (I1). Fully labeled crypts were observed at 14 days post initial staining 
(J1). Finally, 10% of crypts were entirely lineage traced at 90 days after the initial 
injection (K1) (Powell et al., 2012). 
Additionally, LRIG1-positive stem cells were found to have lower proliferation 
character and increased cell cycle repression relative to Lrg5 (leucine rich repeat 
containing G-protein coupled receptor-5)-positive stem cells. This suggests that LRIG1 
expressing cells may be relatively quiescent16. However, irradiation injury to the crypts 
resulted in increased LRIG1-positive stem cell proliferation and repopulation (Powell et 
al., 2014).  This suggests that LRIG1 can be repressed to allow for increased cell 
division when such growth is needed.     
                                                        
16 Quiescent – the cell is in a state of inactivity or dormancy in regards to cell division. 
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LRIG3 
While the morphology of LRIG3 is very similar to that of LRIG1, recent studies 
suggest LRIG3and LRIG1 functionally oppose each other. Specifically, LRIG3 has 
been shown to increase expression of ErbBs 1-4, while LRIG1 promotes LRIG3’s 
proteolytic degradation17 (Rafidi et al., 2013). This opposition isn’t uncommon between 
members of a protein family involved in cellular signaling, and may have evolved as a 
means of autoregulation18. Moreover, these actions suggest LRIG3 might functionally 
oppose LRIG1’s tumor suppressing abilities, possibly as part of a greater mechanism 
used to balance cell growth.  
However, other studies suggest that LRIG3 might actually function as a 
redundant19 tumor suppressor for LRIG1. In one such study, it was discovered that 
Lrig3 double null20 (Lrig3-/-) mice suffered from deformities of the inner ear during 
morphogenesis21 while both Lrig1-/- and Lrig2-/- mice had morphologically normal inner 
ear development (del Rio et al., 2013). However, in Lrig1/Lrig3 double null mice22 
there was a worsening of the inner ear phenotype in sites of LRIG1/LRIG3 co-
expression. This suggests that the inner ear possesses a level of functional redundancy 
between LRIG1 and LRIG3, such that the absence of one protein is functionally 
covered by the presence of the other protein. Furthermore, it is important to note that                                                         
17 Proteolytic degradation – the breakdown of a protein into its component parts such that it is cannot 
function. 
18 Autoregulation – the process of adjusting (or mitigating) a biological system’s response to stimuli; in 
the case of LRIG1 and LRIG3, cell growth repression (via LRIG1’s degradation of EGFRs) is mitigated 
by LRIG3 (which promotes cell growth via upregulation of EGFRs). 
19 Redundant (gene) – one gene with a given biochemical function is support obliquely by a different 
gene that preforms the same function; if one gene is damaged or unable to perform normally, its function 
is taken up by the second gene and so prevents a total collapse of that biochemical function. 
20 Double null (-/-) – in which an organism completely lacks its referenced gene’s product(s); in this paper, 
both alleles of the Lrig3 gene are absent and no Lrig3 gene product is made anywhere within the 
organism.  
21 Morphogenesis – the development of the body of an organism. 
22 Lrig1-/- and Lrig3-/- 
 
 
11  
Lrig1/Lrig3 double null mice displayed multiple defects in multiple tissues, and either 
died in utero23 or at birth. These observations support the theory that multiple tissues 
employ functional redundancy between Lrig1 and Lrig3, and that the absence of both 
results in widespread homeostatic24 dysregulation. Therefore, because LRIG1 generally 
functions as a tumor suppressor via cell growth depression, there is evidence to suggest 
that LRIG3 may also possess similar abilities. 
Unpublished data offers evidence of Lrig3 mRNA localization within the 
colonic crypt (Figure 6). 
                                                        
23 In utero – within the womb. 
24 Homeostasis – the state of stable equilibrium established from dynamic processes; physiological 
homeostasis is vital for an organism’s health. 
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Figure 6: Comparison of Lrig1 and Lrig3 mRNA localization within the colonic crypt 
via in situ hybridization25. 
Lrig1 mRNA is found to be concentrated at the base of the colonic crypt in mice, while 
Lrig3 mRNA appears to be localized from the base of the crypt (overlapping Lrig1 
mRNA expression) up to approximately 2/3 the height of the crypt (unpublished data, 
Coffey Laboratory, Vanderbilt University).  
This evidence places Lrig1 mRNA within the base of the colonic crypt, while Lrig3 
mRNA is found to both overlap Lrig1 mRNA at the base of the crypt as well as extend 
at least halfway up the crypt wall. This suggests that Lrig1 and Lrig3 transcripts interact 
at the very least within the cells located at the bottom of the colonic crypt. Moreover, if 
LRIG3 acts as a redundant tumor suppressor to LRIG1, we can see here that Lrig3 
transcripts are located within a useful position to do so as it covers where LRIG1 is 
normally localized. 
Knowledge of LRIG3 expression in cancer is uncertain, with available evidence 
only suggesting that this protein is tissue- and subcellular localization-dependent in 
regards to cancer prognoses. One study correlated increased LRIG3-expressing cells in                                                         
25 In situ hybridization – labeled complementary DNA, RNA, or nucleic acid probes are used to 
determine the location of specific DNA or RNA sequences in a portion of tissue; in this case, Lrig3 
transcripts were localized within the colonic crypts. 
Lrigl Lrig3 
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cervical adenocarcinoma with prolonged survival (Muller et al). Another study found 
that LRIG3 was an independent prognostic factor in astrocytomas, with elevated levels 
of LRIG3 linked to a better outcome (Guo et al., 2006). These data are similar to the 
data obtained from studies of LRIG1 expression in cancers, and further support the idea 
that LRIG3 may operate as a tumor suppressor, possibly as a redundant pathway for 
LRIG1 function. 
Composite evidence of LRIG3 function 
The composite evidence suggests that LRIG3 can both oppose LRIG1’s tumor 
suppressing function as well as act as a redundant pathway for LRIG1 function, 
possibly as a result of tissue- and subcellular localization- dependency or in the event of 
injury. These seemingly conflicting pieces of evidence only highlight the need for a 
better functional analysis of this protein both within specific tissues and in juxtaposition 
with other members of the LRIG family. And because we know that LRIG1 expression 
levels can be strongly correlated to quite a few cancer prognoses, it is reasonable to 
wonder if LRIG3-expression levels might also better indicate the outcomes of a broader 
range of cancer types. While this paper unfortunately does not provide these intriguing 
results, it does offer a better analysis of the localization of LRIG1 within the colonic 
crypt and, as a result, a better understanding of the possible localization of LRIG3 
within the colonic crypt.  
Background: Immunofluorescence 
Antibodies, or immunoglobulins, are Y-shaped molecules produced by the 
immune system. They target molecules called antigens by specifically binding to a part 
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on the antigen called an epitope (Figure 7). These antigens can be foreign substance in 
the body. 
 
Figure 7: Antibody binding of antigen.  
Unique patterns of amino acids in the variable regions of the antibodies allow for 
specific binding of the antibody to its epitope, which is expressed on the target antigen 
(https://courses.lumenlearning.com/microbiology/chapter/polyclonal-and-monoclonal-
antibody-production/). 
 
This highly specific antibody/antigen interaction is utilized in immunohistochemistry 
(IHC), which is a powerful technique for the identification of specific tissue 
components. Antibodies are created in animal models such that the variable region26 is 
made to bind a desired cell component target. Therefore, when this antibody is washed 
over a tissue sample, the target cell component is bound. Identification of the bound cell 
component can be derived from immunofluorescence, or the attachment of fluorophores 
to the antibodies such that light microscopy can detect antibody localization. 
                                                        
26 Variable region – located on the tips of the Y-shaped antibody, this region is structurally varied 
between each antibody such that many different antigens can be bound to many different antibodies. 
antigen 
epitopes 
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Fluorophores are chemical compounds that can re-emit a colored light upon light 
excitation, and they are either directly or indirectly conjugated to antibodies.27 
                                                        
27 Direct fluorophore conjugation has the fluorophore attached to the antibody that directly binds the cell 
component target. Indirect fluorophore conjugation is when the fluorophore is attached to an antibody 
that targets a different antibody that targets the actual cell component. 
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Hypothesis 
Objectives of study 
There are two objectives to this study: 
1) We will evaluate the average topmost LRIG1-expressing cell within the 
colonic crypt. 
2) We will evaluate the average total number of Ki67/LRIG1 co-positive cells in 
order to create a proliferative character of the colonic crypt. 
These two objectives will be accomplished by comparing wild-type28 (WT) mice with 
Lrig3-/- mice. 
For the first objective, if LRIG1-expressing cells are observed on average to be 
at a higher cell position up the crypt wall in Lrig3-/- mice relative to WT mice, then we 
can say that LRIG1 has shifted up the crypt wall in the absence of Lrig3 product. If 
LRIG1-expressing cells are observed on average to be in the same location between WT 
and Lrig3-/- mice, then we can say that absence of Lrig3 product does not affect LRIG1 
localization within the colonic crypt. Lastly, if LRIG1-expressing cells have moved 
down the crypt wall in Lrig3-/- mice compared to WT mice, we can say that LRIG1 has 
localized at a lower cell position within the colonic crypt in the absence of Lrig3 
product.  
The second objective will be evaluated by counting the number of Ki67/LRIG1 
co-positive cells within colonic crypts that are also analyzed for the first objective. 
Cellular Ki67 expression is correlated with proliferation of the cell, and if analyzed 
within a larger tissue structure can be correlated with that structure’s proliferative index                                                         
28 Wild-type – genetic designation given to indicate that a strain, gene, or characteristic is prevalent 
among organisms in natural conditions, and is distinct from an atypical mutant type. 
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as a whole. As such, the more Ki67/LRIG1 co-positive cells that are counted within a 
colonic crypt, the greater the proliferative index of that crypt; the fewer the number of 
Ki67/LRIG1 co-positive cells within a crypt, the lesser the proliferation of the tissue 
structure as a whole. Comparing the proliferative index of colonic crypts between WT 
and Lrig3-/- mice will allow us to analyze how proliferation of the crypts may change in 
the absence of Lrig3, and thus how Lrig3 may function within the colonic crypts.   
Overall, we can only speculate on the localization of LRIG3 protein within WT 
mice, although we know at the very least that Lrig3 mRNA transcripts are found 
overlapping and just above the LRIG1-expressing cells found in the colonic crypt base. 
Therefore, in regards to the previously mentioned evidence of LRIG1 directly opposing 
LRIG3, we hypothesize that when Lrig3 is not present, LRIG1 will be expressed at 
greater levels within the colonic crypts, and that the colonic crypt will be less 
proliferative as a whole due to the relatively quiescent nature of LRIG1.  
Importance of study 
Regulation of the colon is vital for homeostasis and health of the body as a 
whole. As such, dysregulation of the mechanistic pathways within this organ can lead to 
numerous, sometimes lethal pathologies. One such pathology is tumorigenesis, which 
arises from uncontrolled cell growth. The LRIG protein family has been studied in large 
part because of its interactions with biomolecules that are part of mechanistic pathways 
involved in cell growth. It has been discovered that LRIG1, for example, is a tumor 
suppressor in the colon, as studies have shown tumor formation in response to Lrig1 
deletion (Powell et al., 2014).  
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However, the other LRIG members are less well studied, and as such their 
function and localization in certain tissues is still fairly unknown. LRIG3’s unknown 
function and localization within the colon is one such example. By understanding where 
LRIG1-expressing cells are found in the colonic crypt in absence of Lrig3 products, we 
can better suggest where Lrig3 products might be located in relation to LRIG1within 
the colonic crypt. As such, this study aims to elucidate simple interaction characteristics 
of LRIG1 and Lrig3 products, such that future studies can build upon this data and 
better determine the role and localization of these LRIG members in proximity.  
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Results 
Wild-type (WT) mice were compared against Lrig3-/- mice in order to analyze if 
LRIG1-expressing cells of the colonic crypt localized differently in the absence of Lrig3 
product. We hypothesized that, due to the functional opposition that LRIG1 presents 
against LRIG3, LRIG1-expressing cells would move up the colonic crypt in absence of 
LRIG3 interaction. Preparation of the colons of WT and Lrig3-/- mice was followed by 
immunofluorescence staining of particular cell components. These fluorescent 
components were viewed using light microscopy, and captured images of the stained 
colonic crypts were analyzed in order to determine any shifts in localization of LRIG1-
expression. This was done by analyzing 150 colonic crypts in three, double-
blinded29samples each of WT and Lrig3-/- mice, counting 1) the topmost +position of 
LRIG1-expressing cells, and 2) the total number of Ki67/LRIG1 co-positive cells found 
below the topmost LRIG1-expressing cell. 
Preparation and immunofluorescence of colonic crypts 
 Three colons each from WT and Lrig3-/- mice were cleaned, fixed, and placed 
on slides in anticipation of immunofluorescence staining (see Methods). Each of the six 
mice samples produced twenty tissue samples for analysis. All tissue samples were 
stained for DAPI, Ki67, and LRIG1 (Figure 8).  
 
 
 
                                                        
29 Double-blind (control) – when neither the main experimenter nor any involved colleagues know the 
particulars of a study’s variable; used to prevent bias in a study  
 
 
20  
      
Figure 8: Colonic crypt immunofluorescence under light microscopy.  
Light microscopy displays an image of fluorescently stained colonic crypts, which 
provides a simultaneous view of cell nuclei (blue), proliferating cells (red), and LRIG1-
expressing cells (green). 
Light microscopy of each of the three immunofluorescence stains revealed distinct 
colonic crypts with LRIG1-expresing cells concentrated around the base of the crypt. 
Proliferating cells – marked by Ki67 – were also observed within the crypt; the majority 
of these cells were located in the bottom half of the colonic crypt. 
Counting cells of the colonic crypt 
Each crypt was scored for two data points: 1) the +position of the topmost 
LRIG1-positive cell, and 2) the total number of Ki67/LRIG1 co-positive cells that were 
found below the topmost LRIG1-positive cell (Figure 9).  
DAPI 
Ki67 
LRIG1 
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Figure 9: Counting LRIG1- and Ki67/LRIG1-expressing cells in the colonic crypt.  
Two data points were collected for each crypt selected: 1) the position of the most 
lumenal LRIG1-positive cell (white circle), and 2) the total number of Ki67/LRIG1 co-
positive cells found below the most lumenal LRIG1-positive cell (white triangles). The 
colonic crypt was fluorescently labeled for cell nuclei (blue), proliferating cells (red), 
and LRIG1-expressing cells (green). 
The +position for LRIG1-expressing cells was found by first deciding the cell with 
position 0 (the most basal, or bottommost, cell of the crypt), and then counting up on 
either side of cell 0 until reaching what was determined to be the most lumenal LRIG1-
expressing cell. This cell was designated a +position, and the data for that distinct crypt 
was recorded. Each sample had this data recorded for 50 distinct colonic crypts, and 
each of the 50 crypt’s data was averaged (Figure 10).  
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Figure 10: Analysis of topmost LRIG1-positive cells in the colonic crypts of wild-type 
and Lrig3-/- mice.  
For each of the six mouse samples, 50 colonic crypts were analyzed for the +position of 
the most lumenal LRIG-positive cell. This data was visually compared between the 
wild-type (WT) and Lrig3-/- (3KO) colonic crypt samples. 
Within the same crypt, the total number of Ki67/LRIG1 co-positive cells that were 
below the most lumenal LRIG1-expressing cell were counted and also recorded. Once 
again, each sample’s data was averaged over 50 unique colonic crypts within the sample 
(Figure 11). 
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Figure 11: Analysis of Ki67/LRIG1 co-positive cells in the colonic crypts of wild-type 
and Lrig3-/- mice.  
For each of the six mouse samples, 50 colonic crypts were analyzed for the total 
number of Ki67/LRIG1 co-positive cells. This data was visually compared between the 
wild-type (WT) and Lrig3-/- (3KO) colonic crypt samples. 
The two, averaged data points for each of the six samples is displayed numerically 
below (Table 1). 
 WT1 WT2 WT3 3KO 1 3KO 2 3KO 3 
Total Ki67/LRIG1 co-
positive cells 5.78 4.20 5.64 2.70 5.08 5.32 
Topmost LRIG1-
positive cell 7.02 5.60 9.20 6.48 9.48 10.26 
 
Table 1: Data point averages between the three wild-type and three Lrig3-/- mice 
samples. 
Each of the six samples was analyzed for two data points. The three wild-type (WT) 
samples were numerically compared to the three Lrig3-/- (3KO) samples. 
Once each sample had both data points recorded for each of the 50 colonic crypts, the 
double blind control was removed and the samples were correlated as either WT or 
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Lrig3-/-. Table 2 displays the results of averaging together the samples that were WT 
and Lrig3-/-. 
 WT Lrig3
-/- Change 
Total Ki67/LRIG1 co-
positive cells 5.21 4.37 -0.84 
Topmost LRIG1-
positive cell 7.34 8.74 +1.47 
 
Table 2: Data point averages between wild-type and Lrig3-/- mice. 
Each of the six samples was analyzed for two data points. The three wild-type (WT) 
samples were averaged and then numerically compared to the three Lrig3-/- samples that 
were also averaged. 
The +position for the topmost LRIG1-expressing cell within the colonic crypt was 
different between the WT and Lrig3-/- mice, with the Lrig3-/- mice expressing LRIG1 
approximately 1.47 cells higher up the crypt wall relative to WT (Figure 12). 
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Figure 12: Comparison of the topmost +position of LRIG1-expressing cells in the 
colonic crypt between wild-type and Lrig3-/- mice.  
For each of the two different genetic backgrounds, a total of 150 colonic crypts were 
analyzed and averaged for the topmost +position of LRIG1. An unpaired t-test between 
the two genetic groups determined that the difference is extremely statistically 
significant, with a two-tailed P value less than 0.0001 (see Methods). The standard 
deviation for wild-type (WT) was 2.59, while Lrig3-/- had a standard deviation of 3.02. 
This difference is extremely statistically significant, indicating that the upward shift of 
LRIG1-expressing cells was not random, but the methodical result of the genetic 
difference between the two samples. In this case, we can assert that absence of Lrig3 
within the colonic crypt caused LRIG1 to be expressed approximately 1.47 cells higher 
up the crypt wall.  
The total number of Ki67/LRIG1 co-positive cells within the colonic crypt also 
differed between the WT and Lrig3-/- mice (Figure 13). 
012
345
678
910
  WT   Lrig3-/-Topm
os
t L
RI
G1
-p
os
it
iv
e 
ce
ll 
(+
po
si
ti
on
)
Genetic Background (mice)
Topmost LRIG1-positive +position within the 
colonic crypt
Cell +position• 
 
 
26  
 
Figure 13: Comparison of the total number of Ki67/LRIG1 co-positive cells in the 
colonic crypt between wild-type and Lrig3-/- mice.  
For each of the two different genetic backgrounds, a total of 150 colonic crypts were 
analyzed and averaged for the total number of Ki67/LRIG1 co-positive cells. An 
unpaired t-test between the two genetic groups determined that the difference is very 
statistically significant, with a two-tailed P value less than 0.0017 (see Methods). The 
standard deviation for both wild-type (WT) and Lrig3-/- mice was 2.30. 
In this case, the Lrig3-/- mice had approximately 0.84 fewer Ki67/LRIG1 co-positive 
cells within the colonic crypt relative to WT mice. Again, the difference is statistically 
significant between the two groups of mice, providing evidence that the decrease in 
Ki67/LRIG1 co-positive cells seen in the Lrig3-/- mice was a direct result of the absence 
of Lrig3.  
On average, LRIG1 was expressed approximately 1.47 cells higher up the 
colonic crypt wall in the Lrig3-/- versus the WT mice. However, the Lrig3-/- mice had an 
average of 0.84 fewer Ki67/LRIG1 co-positive cells in their colonic crypts relative to 
WT mice. Thus, in general, the Lrig3-/- colonic crypt had LRIG1-expressing cells higher 
up the crypt wall compared to WT, but had fewer cells that were both proliferating and 
expressing LRIG1 in total.  
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However, after further consideration, it was determined that the two data points 
described above should be re-analyzed to better capture the total statistical significance 
of our findings. As such, one-way analysis of variance (ANOVA) was used to test for 
statistical significance among the three WT samples and the three Lrig3-/- samples. Both 
WT and Lrig3-/- tests for each of the two data points determined that there was indeed 
statistical significance among the two genetic backgrounds, and as such signified that 
we could not determine if there was actual statistical significance between the WT and 
Lrig3-/- mice. These statistics are displayed for the topmost LRIG1-positive cell position 
in Figure 14: 
 
Figure 14: Comparison of topmost LRIG-positive cells in the colonic crypt between 
wild-type and Lrig3-/- mice.  
The three samples of each genetic background were analyzed for statistical significance 
between the 50 colonic crypts counted for each sample. A one-way ANOVA test 
determined that there was statistical significance among both the wild-type (WT) and 
Lrig3-/- samples (p < 0.05). As such, statistical significance could not be determined 
between the WT and Lrig3-/- samples. Bars signify standard deviation for each sample. 
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Figure 15 displays the one-way ANOVA statistics for the total number of Ki67/LRIG1 
co-positive cells within the colonic crypts: 
 
Figure 15: Comparison of Ki67/LRIG1 co-positive cells in the colonic crypt between 
wild-type and Lrig3-/- mice.  
The three samples of each genetic background were analyzed for statistical significance 
between the 50 colonic crypts counted for each sample. A one-way ANOVA test 
determined that there was statistical significance among both the wild-type (WT) and 
Lrig3-/- samples (p < 0.05). As such, statistical significance could not be determined 
between the WT and Lrig3-/- samples. Standard deviation for each sample is signified 
by bars. 
These new statistics suggest that for a more complete analysis of the colonic crypt 
differences between WT and Lrig3-/- mice, we should implement methods that better 
collect and quantify the data. One possibility would be to define a more rigid set of 
parameters for counting the two data points; for examples, the Ki67/LRIG1 co-positive 
cells could be counted in relation to the total cell height of the crypt, making the co-
positive cells a percentage rather than a total number. This would better delineate that 
actual amount of proliferation within a crypt as it would take into account the variances 
of crypt height. Another was to determine statistical significance between the WT and 
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Lrig3-/- mice would be to simply count more overall samples. This would increase 
samples size and provide a more accurate and precise analysis of the two data points. 
Additionally, counting more colonic crypts for the samples already collected would be 
another way to improve accuracy and precision of the two data points.      
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Discussion 
LRIG3 is a member of the leucine rich repeats and immunoglobulin-like 
domains (LRIG) protein family, but only limited research has been done to explore its 
functional role and localization within the body. Conversely, both LRIG1’s function 
and localization is much more defined within the body; for example, LRIG1 is 
definitively known as a tumor suppressor in the colon. As such, LRIG1 provokes 
continued interest from the research community both for its application in cancer 
prognoses and its potential as a tumor therapeutic.  
Due to the similar homology between LRIG1 and LRIG3, there has been 
speculation that LRIG3’s function might possess characteristic that either oppose or 
support LRIG1 function, and indeed, supporting evidence for both of these possibilities 
has been discovered. However, LRIG3’s localization and functionality within the colon 
is still largely undefined. This study analyzes both LRIG1 expression and the 
proliferation index within the colonic crypts of WT and Lrig3-/- mice in order to better 
understand the possible localization and functionality of colonic crypt Lrig3. 
Results of most lumenal LRIG1-positive cell  
The results of this study show that in the absence of Lrig3 product, there is a 
distinct, upward shift in localization of LRIG1-expressing cells within the colonic crypt. 
Specifically, data analysis indicates that LRIG1 is expressed 1.47 cells higher up the 
crypt wall. Keeping in mind that the colonic crypt is only 19-35 cells tall, this already 
appears to be a relatively significant shift in position, and indeed, an unpaired t-test 
affirms this shift to be extremely statistically significant (P < 0.0001) (Sunter et al., 
1979). However, further statistical analysis revealed that there is also statistical 
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significance among the three WT and the three Lrig3-/- samples. As such, the earlier 
data that suggested that LRIG1 localizes higher up the colonic crypt may not be 
accurate. In the interest of treating the earlier results as potentially accurate, we can put 
forth several suggestions as to why LRIG1 migrates upward in the absence of Lrig3, 
based on the conclusion that 1) loss of Lrig3 directly affects LRIG1 localization in 
colonic crypt, and that 2) here is cross-talk between LRIG1 and Lrig3. 
The first scenario is that Lrig3 product suppresses the upward migration of 
LRIG1-expressing cells. This may be done by direct interaction between Lrig3 mRNA 
or protein with LRIG1 protein, Lrig1mRNA, or even the Lrig1 transcription or 
translation processes. Lrig3 product may indirectly inhibit upward LRIG1 migration, as 
previous evidence has shown LRIG1 to degrade LRIG3, so it may be possible that 
without needing to invest time or energy to do so, LRIG1 can extend further up the 
crypt wall. 
A second possibility is that there might be direct suppression of LRIG1 
transcription by Lrig3 products. As such, cells with a certain level of Lrig3 expression 
might hamper the simultaneous production of LRIG1. Regardless of the exact 
mechanistic nuances, some form of cross-talk between LRIG1 and Lrig3 product is the 
most likely reason for the earlier results this study found, as we potentially see a direct 
change in LRIG1 localization in the absence of Lrig3.   
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Results of Ki67/LRIG1 co-positive cell numbers 
Protein Ki67 is expressed in cells that are dividing, and as such, proliferating 
stem- and TA-cells can be localized within a tissue sample by labeling for Ki67 
presence. Evidence has been found that LRIG1-positive intestinal stem cells are 
relatively inactive in terms of their rate of division, suggesting that LRIG1-expressing 
cells may be generally less likely to divide and therefore less likely to express Ki67. 
Therefore, the very statistically significant (P < 0.0017) 0.84 cell decrease in Ki67 and 
LRIG1 co-positive cells in the absence of Lrig3 product is a reasonable observation, as 
the increase in LRIG1 may restrict a more robust rate of cell cycle division within the 
colonic crypt and thus a lack of Ki67. While the most recent statistics call this 
observation into question, we offer a discussion here that is related to the earlier 
statistics that found there was a noticeable change in proliferation index between WT 
and Lrig3-/- colonic crypts. As such, we can suggest that Lrig3 product might either 
directly or indirectly encourage the growth and division of cells. 
 There is further support for the observed decrease of Ki67 within the colonic 
crypts when one considers that LRIG1 suppresses cell growth via the negative 
regulation of EGFRs. In other words, increased LRIG1 expression decreases cell 
growth and thus Ki67 presence. Moreover, LRIG3 has been observed to increase 
growth factor receptors in certain tissues and so increase the rate of cell division; thus, 
absence of Lrig3 product would also contribute to an overall decrease in the rate of cell 
division. Therefore, both the increase in LRIG1-expressing cells and the absence of 
Lrig3 product was likely to contribute to the 0.84 cell decrease in Ki67/LRIG1 co-
positive cells seen within the colonic crypts of Lrig3-/- mice. 
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Due to LRIG1’s role in the homeostasis of cell growth, LRIG1 is a protein of 
interest in studying tumor formation; as such, LRIG3 might also be a protein of interest 
due to evidence of its homology and interaction with LRIG1 in certain tissues. This 
study aims to contribute to the possible characterization of colonic crypt LRIG3 through 
analysis of both colonic crypt LRIG1 and proliferation index, such that future 
researchers might be able to move one step closer in fully elucidating LRIG3 
functionality and localization. 
Future Directions 
Colitis is an inflammation of the colon that results in bloody stool and diarrhea, 
and can be induced in mice through addition of dextrane sulfate sodium (DSS) to a 
mouse’s drinking water. Comparison of phenotypes between WT and genetically 
modified mice can reveal protective, deleterious, or neutral effects as a result of the 
genetic modification. For example, a DSS-treated mouse that has been genetically 
modified to not possess any LRIG1 (Lrig1-/-) has comparatively more blood in their 
stools and a more inflamed colon as viewed by cross section in relation to WT; this 
suggests LRIG1 has a protective effect for the colon against colitis (Powell et al., 2014).  
A future study could analyze the protective, deleterious, or neutral effect of 
LRIG3 in the colon via DSS-induced colitis treatment between WT and Lrig3-/- mice. 
This study would rely upon evaluation of behavioral phenotype and examination of 
tissue cross sections of the colon in mice with DSS-induced colitis. If Lrig3-/- mice 
displayed improved symptoms of colitis relative to WT mice, then LRIG3 would be 
considered to have a deleterious effect against colitis. Conversely, if Lrig3-/- mice 
present with worse symptoms of colitis in comparison to WT mice, than LRIG3 would 
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be considered to have a protective effect against colitis. Lastly, if Lrig3-/- mice 
demonstrate similar symptoms as WT mice, then LRIG3 would be characterized as 
having a neutral effect on colitis. Although the exact biochemical basis for the observed 
effects would not be determined in this study, the results would better elucidate the 
functionality of Lrig3 product within the colon, ideally helping future researchers 
decide how to approach future mechanistic experimentation of LRIG3.  
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Methods 
Colon preparation  
Wild type (WT) and Lrig3-/- mice were sacrificed 12 weeks after birth. The 
colon was washed with 1X phosphate-buffered saline (PBS) solution and fixed flat with 
the lumenal side facing up on a wax surface with 4% paraformaldehyde and PBS buffer. 
The fixed colon was processed in 30% sucrose, after which the processed tissue samples 
were embedded in optimum cutting temperature (O.C.T) ‘frozen’ blocks on dry ice. The 
frozen blocks were stored at -80 °C. The blocks were then sectioned on a cryostat such 
that two, 5µm-thick tissue slices were placed on each glass slide. Each of the six mouse 
samples had a total of ten slides, with a total of twenty tissue sections for each sample 
and a total of sixty sections for each of WT and Lrig3-/- mice. 
Immunofluorescence staining 
The frozen, plated tissue sections were removed from -80 °C storage, air-dried 
for 15 minutes, and passed through three, 3-minute washes of 1X PBS. A hydrophobic 
pen was used to outline the tissue samples on the slides, after which the samples were 
incubated in PBS blocking buffer for 30 minutes in a moistened environment. Primary 
antibodies consisting of a 1:200 directly conjugated rat anti-KI67 PE antibody 
(eBioscience, catalog# 12-5698-82) and a 1:500 goat anti-LRIG1 antibody (Cosmo Bio, 
catalog# 25503-96, lot# 610G0675) were added to the samples and left overnight at 
room temperature.  
The samples were again washed three times for three minutes each in 1X PBS. 
Secondary antibodies of 1:500 donkey anti-goat 647 (Jackson ImmunoResearch, 
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catalog# 705-605-147, lot# 121221) were added to each sample and allowed to incubate 
for one hour. The slides were then washed for three minutes in 1X PBS, then five 
minutes in 1X PBS+DAPI (1:10,000), then again in 1X PBS. Approximately 4 drops of 
n-propyl gallate was added to each slide, covered with a coverslip, and stored at 4 °C. 
Crypt imaging and position counting 
The tissue samples were placed under a fluorescent microscope; crypt 
morphology and biochemical makeup was viewed via the proliferation marker Ki67 
(red), stem cell marker LRIG1 (green), and the cell nucleus (DAPI, blue). Each colored 
stain was its own ‘channel’; a merged channel was the overlap of all three colored 
immunostains into one composite image as seen in Figure 8. 
Each morphologically acceptable colonic crypt was scored on for: 1) the 
topmost +position of LRIG1, and 2) the total number of Ki67 and LRIG1 co-positive 
cells within the crypt but below the topmost LRIG1-positive cell. These data were 
analyzed such that each sample was averaged for topmost +position of LRIG1 and 
Ki67/LRIG1 co-positive cells. Each of the six samples (three WT and three Lrig3-/-) 
were double blinded while counting occurred; after completion of counting, the double 
blind was removed and analysis was done with knowledge of which sample was WT 
and which was Lrig3-/-.  
Statistical significance  
The online tool GraphPad QuickCalcs (https://www.graphpad.com/quickcalcs 
/ttest1.cfm) was used to calculate the unpaired t-test results shown in Figure 12 and 
Figure 13. The two data points for each of Lrig3-/- and WT’s 150 colonic crypts were 
statistically analyzed for P value (p <0.05), statistical significance, and standard 
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deviation via this program. The online tool One-Way ANOVA Calculator 
(http://www.socscistatistics.com/tests/anova/default2.Aspx) was used to calculate the 
one-way ANOVA statistics for Figure 14 and Figure 15. The two data points for the 
three WT and three Lrig3-/- samples were analyzed for P value (p < 0.05) and standard 
deviation of each sample.  
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